Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
Schizophrenia Research|April 2, 2019
Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trialHenry W Mahncke, Sarah-Jane Kim, Annika Rose, et al.
The Journal of Clinical Psychiatry|September 7, 2010
Treatment outcomes of patients with tardive dyskinesia and chronic schizophreniaStanley N Caroff, Vicki G Davis, Del D Miller, et al.
The American Journal of Psychiatry|May 28, 2025
Impact of Polygenic Interactions With Anticholinergic Burden on Cognition and Brain Structure in Psychosis Spectrum DisordersLusi Zhang, Elena I Ivleva, David A Parker, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 26, 2010
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophreniaJoseph L McClay, Daniel E Adkins, Karolina Aberg, et al.
Schizophrenia Research|April 10, 2017
Cognitive burden of anticholinergic medications in psychotic disordersSeenae Eum, S Kristian Hill, Leah H Rubin, et al.
Journal of Affective Disorders|July 19, 2023
Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS studySabrina M Darrow, Diego A Pizzagalli, Moria Smoski, et al.
Biological Psychiatry|September 1, 2004
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteriaMichael F Green, Keith H Nuechterlein, James M Gold, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophreniaChristine E Marx, Richard S E Keefe, Robert W Buchanan, et al.
The Journal of Clinical Psychiatry|June 13, 2012
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trialRichard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.
Schizophrenia Research|March 25, 2023
Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disordersLusi Zhang, Paulo Lizano, Yanxun Xu, et al.
Pageof 24